**Research Highlights**

\(1\) Mechanical strain contributes to the formation of hyperplastic scar in wounds.

\(2\) Nerve density and expression of nerve growth factor are increased in hyperplastic scar tissue.

\(3\) The cutaneous nervous system is involved in mechanical strain-caused hypertrophic scar development.

INTRODUCTION {#sec1-1}
============

Skin is the major protective barrier between an animal and its environment, and its integrity is important for survival. Hypertrophic scarring is a fibroproliferative disease that occurs following deep skin injury, such as burns, abrasion injuries, and deep skin graft donor sites. These scars are frequently painful, reddish, firm, and itchy. They often have a profound negative impact on the quality of life of individuals affected. During the past several decades, many studies have been performed in an effort to determine the etiology of hypertrophic scarring\[[@ref1][@ref2][@ref3][@ref4]\]. Potential etiologies thought to underlie human hypertrophic scar formation include mechanical loading, nerve factors, inflammation, and foreign-body reactions\[[@ref5][@ref6][@ref7][@ref8]\]. Unfortunately, insight into the pathophysiology of hypertrophic scar formation has been hindered by the absence of a reliable animal model\[[@ref9][@ref10][@ref11][@ref12]\]. Aarabi *et al*\[[@ref13]\] demonstrated for the first time that mechanical tension applied to a healing wound is sufficient to produce hypertrophic scars in mice. The striking similarity to human hypertrophic scars suggested that this murine model would be useful to investigate the pathophysiology of human hypertrophic scarring.

Mechanical stimuli have been shown to influence fibroblast processes, such as cell differentiation, proliferation, survival, and matrix production. Mechanical tension is the greatest causative factor of hypertrophic scarring\[[@ref14][@ref15][@ref16][@ref17][@ref18]\]. For several years it has been known that the nerve system of skin plays a role in adult mammalian wound healing and scarring, perhaps *via* the biological effects of neuropeptides, including the proliferation of epithelial, vascular and connective tissue\[[@ref19]\].

Traditionally, nerve growth factor is considered as a chemoattractant that participates in the regulation of cell proliferation, differentiation and myelination of neurons\[[@ref20]\]. However, currently available data suggest that the physiological role of nerve growth factor in the organism is much wider\[[@ref21]\]. Nerve growth factor is secreted and synthesized by a variety of cells, such as inflammatory and repair cells, and its biological effects are diverse and closely related to the process of wound repair. Nerve growth factor participates in the regulatory process of cell proliferation and plays an important role in tissue repair\[[@ref22]\]. Nerve growth factor has been linked to hypertrophic scar and keloid formation in a number of different ways, with strong and persistent expression of nerve growth factor and its receptors shown to occur in fibroblasts of post-burn hypertrophic scars\[[@ref23]\].

We hypothesized that nerve growth factor is one of the mediators connecting mechanical tension and hypertrophic scarring. The aim of this study was to explore the role of mechanical tension in hypertrophic scarring in mice by quantifying nerve density in scar tissue and then examining nerve growth factor expression.

RESULTS {#sec1-2}
=======

Quantitative analysis of experimental animals {#sec2-1}
---------------------------------------------

A total of 40 mice were initially included in the study, and were equally and randomly assigned to the mechanical forces or control groups, receiving mechanical tension on the back skin or no treatment, respectively. All 40 mice were included in the final analysis.

Histological observation of scars {#sec2-2}
---------------------------------

At 2 weeks after injury, the murine scars in the mechanical forces group were raised and showed epidermal thickening with an absence of adnexal structures and hair follicles in the dermis, indicating significantly higher scar thickness. The control group developed very little fibrosis after 2 weeks (Figures [1A](#F1){ref-type="fig"}, [B](#F1){ref-type="fig"}). At 5 weeks after injury, the murine scars in the mechanical forces group remained visible. The control wounds healed with almost no scarring (Figures [1C](#F1){ref-type="fig"}, [D](#F1){ref-type="fig"}).

![Histological observation of scars at 2 weeks post-injury.\
Gross (A) and histological (B; hematoxylin-eosin staining, × 10) images showed that in the mechanical forces group, a loss of rete pegs, adnexae, and hair follicles, the classic histological features of human hypertrophic scars, were observed.\
Gross (C) and histological (D; hematoxylin-eosin staining, × 10) images showed that very little fibrosis formed in the control group. The dashed lines in B and D show the scar tissue.](NRR-8-1576-g001){#F1}

Nerve fibers in hypertrophic scars {#sec2-3}
----------------------------------

At 2 weeks after injury, brown immunoreactive S100 positive nerve fibers were visible in the scar tissue layer in the mechanical forces group, with dot-, short bar- or beansprout-shaped morphologies ([Figure 2](#F2){ref-type="fig"}). The nerve density was increased significantly compared with the control group.

![Immunoreactivity of S100 in skin scars after injury (immunohistochemical staining, × 400).\
Brown immunoreactive S100 positive nerve fibers were visible in the scar tissue layer in the mechanical forces group at 2 weeks (A) and 5 weeks (B) post-injury, while they were nearly invisible in the scar tissue layer in the control group (C).](NRR-8-1576-g002){#F2}

At 5 weeks after injury, the nerve density in the mechanical forces group remained significantly elevated compared with the control group. There were no significant differences in the nerve density between 2 weeks and 5 weeks post-injury in the mechanical forces group ([Table 1](#T1){ref-type="table"}).

###### 

Effect of mechanical tension on the nerve density (nerve number/total dermal area) in skin scar tissues

![](NRR-8-1576-g003)

Nerve growth factor expression in skin scars {#sec2-4}
--------------------------------------------

Western blot analysis was used to measure nerve growth factor production in the scars. At 2 weeks post-injury, nerve growth factor expression levels in the mechanical forces group were significantly upregulated compared with the control group. At 5 weeks post-injury, nerve growth factor levels in the mechanical forces group remained significantly elevated compared with the control. There were no significant differences in the nerve growth factor levels between 2 and 5 weeks post-injury in the mechanical forces group ([Figure 3](#F3){ref-type="fig"}).

![Effect of mechanical tension on the expression of nerve growth factor (NGF) in skin scars (western blot analysis).\
^a^*P* \< 0.01, *vs*. control group (Student\'s *t*-test). Data are expressed as mean ± SEM with absorbance ratio of NGF to β-actin.](NRR-8-1576-g004){#F3}

DISCUSSION {#sec1-3}
==========

In this study, we used murine models of hypertrophic scars that are grossly and histologically identical to human hypertrophic scars, produced by applying exogenous mechanical forces to healing murine wounds. Our experimental findings showed that the nerve density was increased in the scar tissue caused by mechanical tension. Our previous study suggested that compared with mature scars, hypertrophic scars exhibited a greater number of nerve fibers, with more serious pathologies\[[@ref24]\]. These findings are consistent with the previous histological findings of increased nerve numbers in human hypertrophic scar samples from several investigators\[[@ref25][@ref26][@ref27][@ref28][@ref29][@ref30][@ref31][@ref32]\].

Furthermore, our study found that the expression levels of nerve growth factor in the scar tissue were increased by mechanical tension. Mechanical tension, including skin stretching, stimulates mechanosensitive nociceptors on sensory fibers in the skin. Stimulated fibers release neuropeptides and overexpressed nerve growth factor may induce the hyper-release of neuropeptides from sensory fibers, resulting in the accumulation of neuropeptides, even in the absence of mechanical tension, once the malignant cycle has begun\[[@ref33][@ref34][@ref35][@ref36][@ref37][@ref38][@ref39][@ref40]\].

In conclusion, nerve distribution in murine models of wound-healing mechanical tension-induced scars correlates well with human scars, thus providing additional evidence that this scar model may be valuable for understanding the pathophysiology of human hypertrophic scar formation.

MATERIALS AND METHODS {#sec1-4}
=====================

Design {#sec2-5}
------

A randomized, controlled, animal experiment.

Time and setting {#sec2-6}
----------------

The study was performed at the Laboratory Animal Center and Central Laboratory of Shandong Provincial Hospital Affiliated to Shandong University from November 2007 to June 2011.

Materials {#sec2-7}
---------

A total of 40 clean, female C57BL/6 mice weighing 20 ± 5 g, 8 weeks old, were provided by the Laboratory Animal Center of Shandong University, China (license No. SCXK (Lu) 2003-0004). Animals received regular feeding and free water, with no adverse factors. Disposal of animals during the experiments was consistent with the Animal Ethics Committee of Shandong Provincial Hospital Affiliated to Shandong University, China.

Methods {#sec2-8}
-------

### Establishment of mouse scar models {#sec3-1}

Mice were anesthetized with intraperitoneal injection of 3% pentobarbital (1 mL/kg), and the back hair was removed. Murine models of hypertrophic scar were established according to Aarabi's method\[[@ref13]\] with some modifications. In brief, biomechanical loading devices were constructed from 22-mm expansion screws (Great Lakes Orthodontic Products, Tonawanda, NY, USA). A midline skin incision, approximately 2 cm long, was made on the dorsum of the mouse, which was subsequently closed with 6-0 nylon sutures. Four days later, the sutures were removed from the scars, and a loading device was carefully secured with 6-0 nylon sutures. The wound in the mechanical forces group was loaded every other day. Prior to applying tension, two points were identified on either side of the scars using a permanent marking pen. Tension on the wounds was created by carefully extracting the expansion screws by 2 mm on day 4 and 4 mm every other day thereafter. During the periods between extractions, stress relaxation was observed because of the natural elongation of skin, resulting in a continuous decrease in the force acting on the wounds. To compensate, tension was reapplied every other day up to 2 weeks. Scar tissue was harvested at 2 weeks after initiation of tension by carefully extracting the expansion screws.

The wound in the control group served as a control, in which the device was not activated (expansion screws were used without loading).

### Collection of tissue samples {#sec3-2}

The backs of the animals were shaved prior to morphometric measurements. Scar tissue (0.5-cm in length) was harvested at 2 and 5 weeks after the initiation of tension, and then fixed in formalin, gradient ethanol dehydrated, paraffin-embedded, and sliced into 5-μm thick sections with a microtome (Leica CM3050S, Leica, Germany) for use in further experiments.

### Hematoxylin-eosin staining {#sec3-3}

The sections were dewaxed using xylene and washed with alcohol and water, followed by hematoxylin staining for 5 minutes. Sections were washed with tap water, differentiated with hydrochloric acid for 30 seconds, soaked in tap water for 15 minutes, and stained with eosin for 2 minutes. Sections were then dehydrated, cleared and mounted. The microstructural changes in tissues were observed by microscopy (Type BX51, Olympus, Tokyo, Japan).

### Detection of S100 immunoreactivity in the scar by immunohistochemistry {#sec3-4}

The specimens were embedded in paraffin and cut into 4-μm-thick sections for immunohistochemical staining. Tissue sections were deparaffinized and microwaved for antigen retrieval, followed by incubation in 3% H~2~O~2~ for 10 minutes. Nonspecific binding of antibodies was inhibited by incubation in 5% normal goat serum for 20 minutes in a humidified chamber. Sections were washed with PBS three times, and incubated with rabbit anti-S100 polyclonal antibody (1:100; Abcam, Cambridge, MA, USA) for 40 hours at 4°C. After three washes with PBS, tissue sections were incubated with biotinylated goat anti-rabbit IgG (1:1 000; Boster, Wuhan, Hubei Province, China) for 30 minutes at room temperature. After washing with PBS, slides were incubated in streptavidin-peroxidase complex for 30 minutes at 37°C, washed three times, visualized using diazoaminobenzene, and counterstained with hematoxylin. As a negative control, sections were stained without the addition of a primary antibody. Contents of S100 were analyzed using morphological analysis software (Leica Qwind Pro V3.3.1) to perform semi-quantitative analysis. All measurements were undertaken in a blinded manner.

### Detection of nerve growth factor expression in the scar by western blot analysis {#sec3-5}

Total protein was extracted from scar tissue samples using tissue protein extraction reagent (Pierce, Rockford, IL, USA). Protein concentrations were determined using the Bradford method (Bio-Rad, Richmond, CA, USA). Protein extracts from the scar tissue (20 μg) were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Blots were transferred to a nitrocellulose membrane (Bio-Rad), and blocked with blocking solution (3% bovine serum albumin in 1 Tween 20-Tris buffered saline, consisting of 20 mmol/L Tris HCl, pH 7.4, 150 mmol/L NaCl, and 0.1% Tween 20) for 2 hours at 4°C. Then, tissues were probed with rabbit anti-nerve growth factor polyclonal antibody (1:100; Abcam). Rabbit anti-mouse beta-actin antibody (mouse monoclonal; 1:5 000; Sigma-Aldrich, St. Louis, MO, USA) was used as an internal loading control. The blots were incubated overnight at 4°C with each antibody. Peroxidase goat anti-rabbit IgG (1:2 000; Santa Cruz Biotechnology, Santa Cruz, CA, USA) was used as a secondary antibody. Immunoreactivity was detected by enhanced chemiluminescence kit (Amersham Biosciences, Little Chalfont, Buckinghamshire, UK). Film autoradiograms were exposed for 10--30 minutes. The absorbance values of the target protein were measured using the image analysis program 'Image J' (Toronto Western Research Institute University Health Network, Toronto, ON, Canada). The absorbance ratio of target protein to internal reference was represented as the relative amount of target protein.

### Statistical analysis {#sec3-6}

Data were analyzed by SPSS 10.0 statistical analysis software (SPSS, Chicago, IL, China), and experimental data were expressed as mean ± SEM. The differences between the two groups were analyzed by Student's *t*-test. A value of *P* \< 0.05 was considered significantly significant.
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